Rami Batal - Net Worth and Insider Trading

Rami Batal Net Worth

The estimated net worth of Rami Batal is at least $8,310 dollars as of 2024-09-21. Rami Batal is the Senior Officer of Antibe Therapeutics Inc and owns about 28,169 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $8,310. Details can be seen in Rami Batal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rami Batal has not made any transactions after 2020-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Rami Batal

To

Rami Batal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rami Batal owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .

Click here to see the complete history of Rami Batal’s form 4 insider trades.

Insider Ownership Summary of Rami Batal

Ticker Comapny Transaction Date Type of Owner
TSX:ATE Antibe Therapeutics Inc 2020-09-21 Senior Officer

Rami Batal Latest Holdings Summary

Rami Batal currently owns a total of 1 stock. Rami Batal owns 28,169 shares of Antibe Therapeutics Inc (TSX:ATE) as of September 21, 2020, with a value of $8,310.

Latest Holdings of Rami Batal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:ATE Antibe Therapeutics Inc 2020-09-21 28,169 0.30 8,310

Holding Weightings of Rami Batal


Rami Batal Form 4 Trading Tracker

According to the SEC Form 4 filings, Rami Batal has made a total of 1 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 28,169 shares on September 21, 2020, which cost Rami Batal around $98,592.

Insider Trading History of Rami Batal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rami Batal Trading Performance

GuruFocus tracks the stock performance after each of Rami Batal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rami Batal is 3.71%. GuruFocus also compares Rami Batal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rami Batal within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rami Batal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rami Batal

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.86 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.57 LIMIT LIMIT LIMIT LIMIT LIMIT

Rami Batal Ownership Network

Ownership Network List of Rami Batal

No Data

Ownership Network Relation of Rami Batal

Insider Network Chart

Rami Batal Owned Company Details

What does Antibe Therapeutics Inc do?

Who are the key executives at Antibe Therapeutics Inc?

Rami Batal is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .

Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Antibe Therapeutics Inc Insider Transactions

No Available Data

Rami Batal Mailing Address

Above is the net worth, insider trading, and ownership report for Rami Batal. Currently GuruFocus does not have mailing address information for Rami Batal.

Discussions on Rami Batal

No discussions yet.